U.S. PHARMACOPEIA

Search USP29  
Carbamazepine
Click to View Image
C15H12N2O 236.27

5H-Dibenz[b,f]azepine-5-carboxamide.
5H-Dibenz[b,f]azepine-5-carboxamide [298-46-4].
» Carbamazepine contains not less than 98.0 percent and not more than 102.0 percent of C15H12N2O, calculated on the dried basis.
Packaging and storage— Preserve in tight containers.
X-ray diffraction 941 The X-ray diffraction pattern conforms to that of USP Carbamazepine RS, similarly determined.
Acidity— Add 2.0 g to 40.0 mL of water, mix for 15 minutes, and filter through paper. To a 10.0-mL aliquot of the solution so obtained add 1 drop of phenolphthalein TS, and titrate with 0.01 N sodium hydroxide VS from a 10-mL buret. Perform a blank determination, and make any necessary correction. Not more than 1.0 mL of 0.010 N sodium hydroxide is required for each 1.0 g of Carbamazepine.
Alkalinity— To a 10.0-mL aliquot of the solution prepared in the test for Acidity add 1 drop of methyl red TS, and titrate with 0.01 N hydrochloric acid VS from a 10-mL buret. Perform a blank determination, and make any necessary correction. Not more than 1.0 mL of 0.010 N hydrochloric acid is required for each 1.0 g of Carbamazepine.
Loss on drying 731 Dry it at 105 for 2 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.1%, a 2.0-g test specimen being used.
Chloride 221 Boil 1.0 g with 20.0 mL of water for 10 minutes, cool, again adjust the volume, and filter: a 10.0-mL portion of the filtrate shows no more chloride than corresponds to 0.10 mL of 0.020 N hydrochloric acid (0.014%).
Heavy metals, Method II 231: 0.001%.
Chromatographic purity—
Mobile phase and System suitability solution Proceed as directed in the Assay.
Standard solution— Dissolve accurately weighed quantities of USP Carbamazepine RS, 10,11-dihydrocarbamazepine, and iminostilbene in methanol, and dilute quantitatively, and stepwise if necessary, with methanol to obtain a solution having known concentrations of about 0.02 mg per mL of each component. Transfer 5.0 mL of this solution to a 100-mL volumetric flask, dilute with a mixture of methanol and water (50:50) to volume, and mix.
Test solution— Transfer about 100 mg of Carbamazepine, accurately weighed, to a 50-mL volumetric flask, and dissolve in and dilute with methanol to volume. Transfer 25.0 mL of this solution to a 50-mL volumetric flask, add about 20 mL of water, and shake. Allow the mixture to cool to room temperature, and dilute with water to volume.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 230-nm detector and a 4.6-mm × 25-cm column that contains packing L10. The flow rate is about 1.5 mL per minute. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the resolution, R, between the 10,11-dihydrocarbamazepine and carbamazepine is not less than 1.70; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the peak responses. Calculate the quantities, in mg, of 10,11-dihydrocarbamazepine and iminostilbene in the portion of Carbamazepine taken by the formula:
100C(ri / rSi),
in which C is the concentration, in mg per mL, of 10,11-dihydrocarbamazepine or iminostilbene in the Standard solution; and ri and rSi are the peak responses obtained for either 10,11-dihydrocarbamazepine or iminostilbene from the Test solution and the corresponding peak obtained from the Standard solution, respectively. Calculate the quantities, in mg, of all other impurities found in the portion of Carbamazepine taken by the formula:
100C(ri / rS),
in which ri is the peak response for any other impurity; and rS is the peak response for carbamazepine obtained from the Standard solution: not more than 0.2% of any individual impurity is found; and the total of all impurities (including 10,11-dihydrocarbamazepine and iminostilbene) is not more than 0.5%.
Organic volatile impurities, Method V 467: meets the requirements.
Solvent— Use dimethyl sulfoxide.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a 1000-mL mixture of water, methanol, and tetrahydrofuran (85:12:3), add 0.22 mL of formic acid, mix, then add 0.5 mL of triethylamine, and mix. Filter and degas. Make adjustments if necessary (see System Suitability under Chromatography 621).
System suitability solution— Dissolve accurately weighed quantities of USP Carbamazepine RS and 10,11-dihydrocarbamazepine in methanol, and dilute quantitatively, and stepwise if necessary, with methanol to obtain a solution having known concentrations of about 0.1 and 0.5 mg per mL, respectively. Transfer 5.0 mL of this solution to a 50-mL volumetric flask, and dilute with a mixture of methanol and water (1:1) to volume.
Standard preparation— Dissolve an accurately weighed quantity of USP Carbamazepine RS in methanol, and dilute quantitatively with methanol to obtain a solution having a known concentration of about 2 mg per mL. Transfer 5.0 mL of this solution to a 50-mL volumetric flask, and dilute with a mixture of methanol and water (1:1) to volume.
Assay preparation— Transfer about 100 mg of Carbamazepine, accurately weighed, to a 50-mL volumetric flask, and dissolve in and dilute with methanol to volume. Transfer 5.0 mL of this solution to a 50-mL volumetric flask, and dissolve in and dilute with a mixture of methanol and water (1:1) to volume.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 230-nm detector and a 4.6-mm × 25-cm column that contains packing L10. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation and the System suitability solution, and record the peak responses as directed for Procedure: the resolution, R, between 10,11-dihydrocarbamazepine and carbamazepine in the System suitability solution is not less than 1.70; and the relative standard deviation for replicate injections of the Standard preparation is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C15H12N2O in the portion of Carbamazepine taken by the formula:
500C(rU / rS),
in which C is the concentration, in mg per mL, of USP Carbamazepine RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Ravi Ravichandran, Ph.D., Senior Scientist
Expert Committee : (MDPP05) Monograph Development-Psychiatrics and Psychoactives
USP29–NF24 Page 369
Phone Number : 1-301-816-8330